SUMMARY The size and composition ofthe bile salt pool has been measured in patients with untreated coeliac disease and in control subjects. The total bile salt pool was markedly increased in coeliac patients, the average being 9.2 grams compared with 3.1 grams in controls. Taurocholate synthesis was normal, consistent with its enlarged pool and prolonged half-life. Half-life and pool size were significantly correlated. The composition of the bile salt pool was virtually identical in the two groups. Our findings suggest that as the enterohepatic circulation is slowed by gallbladder inertia, so hepatic surveillance of pool size is diminished.We have recently shown that in patients with untreated coeliac disease the gallbladder is relatively inert and the enterohepatic circulation of bile salts more sluggish than normal (Low-Beer, Heaton, Heaton, and Read, 1971). We attributed this to a failure of the damaged upper small intestinal mucosa to release cholecystokinin. This paper is concerned with the effect of the disease on the size of the bile salt pool, its composition, and its daily rate of turnover.
Subjects and MethodsPatients with adult coeliac disease, in whom jejunal biopsy showed subtotal villous atrophy, and who were taking an unrestricted diet, volunteered to undertake these studies; they were compared with a group of age-matched volunteers with no history of gastrointestinal disease drawn from members of staff, hospital outpatients, and medical students. All analyses were performed on bile aspirated after an overnight fast through a tube in the duodenum. Bile flow was stimulated by an iv injection of 10-40 Ivy dog units of cholecystokinin. (Bruusgaard, 1970). The specificity of the salicylaldehyde method for measuring deoxycholic acid is shown in figure 1. In this experiment, the effect of increasing amounts of chenodeoxycholic acid on the absorbance at 700 ,u due to fixed amounts of glycodeoxycholic acid was measured. Chenodeoxycholic acid produced 3 % of the absorbance compared with equimolar amounts of glyco-PM